首页 正文

The new TRR 412 Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathophysiological Mechanisms to Translation into Tailored Therapeutic Concepts (Berlin / Dresden)

{{output}}
Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disease worldwide, affecting around 30% of the population. It represents the hepatic manifestation of the metabolic syndrome and can progress to severe complic... ...